首页 > 最新文献

Critical Pathways in Cardiology最新文献

英文 中文
Does Inclusion of Emergency Medicine (EM) Residents in ECG Screening for STEMI Change the Time to Catheterization Lab Activation? 将急诊医学(EM)住院医师纳入STEMI心电图筛查是否会改变导管实验室启动时间?
Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1097/HPC.0000000000000320
Sarah Aly, Kelsey Coolahan, Kirk Tomlinson, Duncan Grossman, Joseph Bove, Steven Hochman

Background: Emergency medicine physicians must rapidly obtain and interpret an electrocardiogram (ECG) to quickly identify life-threatening cardiac emergencies such as ST-elevation myocardial infarction (STEMI). Although ECG interpretation is a critical component of residency education, few high-powered studies exploring the accuracy of resident ECG interpretation exist.

Objectives: This study aims to evaluate whether or not the inclusion of Third Year Emergency Medicine Resident ECG interpretations is noninferior to attending-only ECG interpretations in regard to time to STEMI activation.

Methods: This was a retrospective noninferiority study of STEMI activation times before and after the inclusion of Third Year Emergency Medicine Resident resident ECG interpretations into the workflow at an academic, urban tertiary care center between November 2020 and April 2022, excluding prehospital activations. The primary outcome was the proportion of successful STEMI activations initiated within 5 minutes of ECG completion. An absolute decrease of 10% between groups was chosen as the noninferiority margin.

Results: In the attending-only group, 26 (66.7%) cases resulted in successful STEMI activations compared to 31 cases (77.5%) in the combined group. The proportion of successful STEMI activations did not differ with resident screening, X 2 = 1.15, P = 0.28. The absolute difference between groups' successful activations was an increase of 11%, which lies within the noninferiority margin (+11%, 95% confidence interval, -8.68% to 30.7%). Average times to STEMI activation in the attending-only and combined groups were 7.59 minutes (Standard Deviation [SD], 10.19) and 5.13 minutes (SD, 6.95), respectively. Average door-to-balloon times for those undergoing Percutaneous Coronary Intervention were 72.74 minutes (SD, 20.76) in the attending-only group and 89.90 minutes (SD, 67.74) in the combination group. Two sample t-test showed no statistically significant difference between the 2 groups for average time to STEMI activation (difference = 2.46 minutes, 95% CI, -1.46 to 6.38) and average door-to-balloon time (difference = 17.16, 95% CI, -39.73 to 5.41).

Conclusion: The inclusion of emergency medicine PGY-3 residents in the ECG screening workflow is noninferior to attending-only interpretation of ECGs with regard to STEMI activation time.

背景:急诊医师必须快速获取和解读心电图(ECG),以快速识别危及生命的心脏紧急情况,如st段抬高型心肌梗死(STEMI)。虽然心电解释是住院医师教育的重要组成部分,但很少有高强度的研究探索住院医师心电解释的准确性。目的:本研究旨在评估在STEMI激活时间方面,纳入急诊医学三年级住院医师ECG解释是否不逊色于仅就诊的ECG解释。方法:这是一项回顾性非劣效性研究,研究了2020年11月至2022年4月期间,一家学术性城市三级医疗中心将三年级急诊医师住院医师心电图解读纳入工作流程前后的STEMI激活时间,不包括院前激活。主要终点是心电图完成后5分钟内成功启动STEMI的比例。选择组间绝对下降10%作为非劣效性边际。结果:在单独护理组中,26例(66.7%)成功激活STEMI,而联合治疗组为31例(77.5%)。STEMI成功激活的比例与住院筛查没有差异,x2 = 1.15, P = 0.28。两组之间成功激活的绝对差异增加了11%,这在非劣效性范围内(+11%,95%置信区间,-8.68%至30.7%)。单独护理组和联合护理组到STEMI激活的平均时间分别为7.59分钟(标准差[SD], 10.19)和5.13分钟(SD, 6.95)。经皮冠状动脉介入治疗组从门到球囊的平均时间为72.74分钟(SD, 20.76),联合治疗组为89.90分钟(SD, 67.74)。双样本t检验显示,两组间STEMI平均激活时间(差异= 2.46分钟,95% CI, -1.46 ~ 6.38)和平均门到球囊时间(差异= 17.16,95% CI, -39.73 ~ 5.41)无统计学差异。结论:将急诊医学PGY-3住院医师纳入心电图筛查工作流程,其对STEMI激活时间的解读不逊于仅由主治医师解读心电图。
{"title":"Does Inclusion of Emergency Medicine (EM) Residents in ECG Screening for STEMI Change the Time to Catheterization Lab Activation?","authors":"Sarah Aly,&nbsp;Kelsey Coolahan,&nbsp;Kirk Tomlinson,&nbsp;Duncan Grossman,&nbsp;Joseph Bove,&nbsp;Steven Hochman","doi":"10.1097/HPC.0000000000000320","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000320","url":null,"abstract":"<p><strong>Background: </strong>Emergency medicine physicians must rapidly obtain and interpret an electrocardiogram (ECG) to quickly identify life-threatening cardiac emergencies such as ST-elevation myocardial infarction (STEMI). Although ECG interpretation is a critical component of residency education, few high-powered studies exploring the accuracy of resident ECG interpretation exist.</p><p><strong>Objectives: </strong>This study aims to evaluate whether or not the inclusion of Third Year Emergency Medicine Resident ECG interpretations is noninferior to attending-only ECG interpretations in regard to time to STEMI activation.</p><p><strong>Methods: </strong>This was a retrospective noninferiority study of STEMI activation times before and after the inclusion of Third Year Emergency Medicine Resident resident ECG interpretations into the workflow at an academic, urban tertiary care center between November 2020 and April 2022, excluding prehospital activations. The primary outcome was the proportion of successful STEMI activations initiated within 5 minutes of ECG completion. An absolute decrease of 10% between groups was chosen as the noninferiority margin.</p><p><strong>Results: </strong>In the attending-only group, 26 (66.7%) cases resulted in successful STEMI activations compared to 31 cases (77.5%) in the combined group. The proportion of successful STEMI activations did not differ with resident screening, X 2 = 1.15, P = 0.28. The absolute difference between groups' successful activations was an increase of 11%, which lies within the noninferiority margin (+11%, 95% confidence interval, -8.68% to 30.7%). Average times to STEMI activation in the attending-only and combined groups were 7.59 minutes (Standard Deviation [SD], 10.19) and 5.13 minutes (SD, 6.95), respectively. Average door-to-balloon times for those undergoing Percutaneous Coronary Intervention were 72.74 minutes (SD, 20.76) in the attending-only group and 89.90 minutes (SD, 67.74) in the combination group. Two sample t-test showed no statistically significant difference between the 2 groups for average time to STEMI activation (difference = 2.46 minutes, 95% CI, -1.46 to 6.38) and average door-to-balloon time (difference = 17.16, 95% CI, -39.73 to 5.41).</p><p><strong>Conclusion: </strong>The inclusion of emergency medicine PGY-3 residents in the ECG screening workflow is noninferior to attending-only interpretation of ECGs with regard to STEMI activation time.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10197047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Impact of HEART Score Decision Aid on Coronary Computed Tomography Angiography Utilization and Diagnostic Yield in the Emergency Department. HEART评分辅助决策对急诊科冠状动脉ct血管造影应用和诊断率的影响。
Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1097/HPC.0000000000000318
Brian J McMahon, Pragati Shrestha, Henry C Thode, Eric J Morley, Ballakur Rao, George-Abraam Tawfik, Akshitha Adhiyaman, Catherine Devitt, Nisha Godbole, Joseph Pizzuti, Kunal Shah, Bernardus Willems, Peter McKenna, Adam J Singer

Objective: Emergency physicians are challenged to efficiently and reliably risk stratify patients presenting with chest pain (CP) to optimize diagnostic testing and avoid unnecessary hospital admissions. The objective of our study was to evaluate the impact of a HEART score-based decision aid (HSDA) integrated in the electronic health record on coronary computed tomography angiography (CCTA) utilization and diagnostic yield in adult emergency department (ED) CP patients with suspected acute coronary syndrome.

Methods: We conducted a before and after study to determine whether implementation of a mandatory computerized HSDA would reduce CCTA utilization in ED CP patients and improve the diagnostic yield of obstructive coronary artery disease (CAD) (≥50%). We included all adult ED CP patients with suspected acute coronary syndrome during the first 6 months of 2018 (before) and 2020 (after) at a large academic center. CCTA utilization and obstructive CAD yield were compared in patients before and after implementing the HSDA using χ2 tests. Secondarily, we assessed the association of HEART scores and CCTA results.

Results: Of the 3095 CP patients during the before study period, 733 underwent CCTA. Of the 2692 CP patients during the after study period, 339 underwent CCTA. CCTA utilization before and after HSDA was 23.4% [95% confidence interval (95% CI), 22.2-25.2] and 12.6% (95% CI, 11.4-13.0), respectively; mean difference was 11.1% (95% CI, 0.9-13.0). Among 1072 patients undergoing CCTA, mean (SD) age and percent females before versus after HSDA were 54 (11) versus 56 (11) years and 50% versus 49%, respectively. We included 1014 patients (686 before and 328 after) for the yield analysis. Obstructive CAD was present in 15% (95% CI, 12.7-17.9) and 20.1% (95% CI, 16.1-24.7) before and after HSDA, respectively; mean difference was 4.9% (95% CI, 0.1-10.1).

Conclusions: Implementation of a mandatory electronic health record HSDA aid reduced ED CCTA utilization by half and improved the diagnostic yield.

目的:急诊医生面临的挑战是如何有效、可靠地对胸痛(CP)患者进行风险分层,以优化诊断检测并避免不必要的住院。本研究的目的是评估电子健康记录中基于心脏评分的决策辅助(HSDA)对疑似急性冠状动脉综合征的成人急诊科(ED) CP患者冠状动脉ct血管造影(CCTA)使用率和诊断率的影响。方法:我们进行了一项前后研究,以确定实施强制性计算机化HSDA是否会降低ED CP患者的CCTA使用率,并提高阻塞性冠状动脉疾病(CAD)的诊断率(≥50%)。我们在一个大型学术中心纳入了2018年前6个月(之前)和2020年(之后)期间疑似急性冠状动脉综合征的所有成年ED CP患者。采用χ2检验比较实施HSDA前后患者CCTA使用率和阻塞性CAD产率。其次,我们评估了HEART评分与CCTA结果的相关性。结果:在研究前的3095例CP患者中,733例接受了CCTA。在研究结束后的2692例CP患者中,339例接受了CCTA。HSDA前后CCTA使用率分别为23.4%[95%可信区间(95% CI), 22.2-25.2]和12.6% (95% CI, 11.4-13.0);平均差异为11.1% (95% CI, 0.9-13.0)。在1072例接受CCTA的患者中,HSDA前后的平均(SD)年龄和女性比例分别为54(11)岁和56(11)岁,50%和49%。我们纳入了1014例患者(治疗前686例,治疗后328例)进行产率分析。HSDA前后分别有15% (95% CI, 12.7-17.9)和20.1% (95% CI, 16.1-24.7)存在阻塞性CAD;平均差异为4.9% (95% CI, 0.1-10.1)。结论:强制性电子健康记录HSDA辅助的实施将ED CCTA的使用率降低了一半,并提高了诊断率。
{"title":"Impact of HEART Score Decision Aid on Coronary Computed Tomography Angiography Utilization and Diagnostic Yield in the Emergency Department.","authors":"Brian J McMahon,&nbsp;Pragati Shrestha,&nbsp;Henry C Thode,&nbsp;Eric J Morley,&nbsp;Ballakur Rao,&nbsp;George-Abraam Tawfik,&nbsp;Akshitha Adhiyaman,&nbsp;Catherine Devitt,&nbsp;Nisha Godbole,&nbsp;Joseph Pizzuti,&nbsp;Kunal Shah,&nbsp;Bernardus Willems,&nbsp;Peter McKenna,&nbsp;Adam J Singer","doi":"10.1097/HPC.0000000000000318","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000318","url":null,"abstract":"<p><strong>Objective: </strong>Emergency physicians are challenged to efficiently and reliably risk stratify patients presenting with chest pain (CP) to optimize diagnostic testing and avoid unnecessary hospital admissions. The objective of our study was to evaluate the impact of a HEART score-based decision aid (HSDA) integrated in the electronic health record on coronary computed tomography angiography (CCTA) utilization and diagnostic yield in adult emergency department (ED) CP patients with suspected acute coronary syndrome.</p><p><strong>Methods: </strong>We conducted a before and after study to determine whether implementation of a mandatory computerized HSDA would reduce CCTA utilization in ED CP patients and improve the diagnostic yield of obstructive coronary artery disease (CAD) (≥50%). We included all adult ED CP patients with suspected acute coronary syndrome during the first 6 months of 2018 (before) and 2020 (after) at a large academic center. CCTA utilization and obstructive CAD yield were compared in patients before and after implementing the HSDA using χ2 tests. Secondarily, we assessed the association of HEART scores and CCTA results.</p><p><strong>Results: </strong>Of the 3095 CP patients during the before study period, 733 underwent CCTA. Of the 2692 CP patients during the after study period, 339 underwent CCTA. CCTA utilization before and after HSDA was 23.4% [95% confidence interval (95% CI), 22.2-25.2] and 12.6% (95% CI, 11.4-13.0), respectively; mean difference was 11.1% (95% CI, 0.9-13.0). Among 1072 patients undergoing CCTA, mean (SD) age and percent females before versus after HSDA were 54 (11) versus 56 (11) years and 50% versus 49%, respectively. We included 1014 patients (686 before and 328 after) for the yield analysis. Obstructive CAD was present in 15% (95% CI, 12.7-17.9) and 20.1% (95% CI, 16.1-24.7) before and after HSDA, respectively; mean difference was 4.9% (95% CI, 0.1-10.1).</p><p><strong>Conclusions: </strong>Implementation of a mandatory electronic health record HSDA aid reduced ED CCTA utilization by half and improved the diagnostic yield.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9687692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of 1-year Follow-up Echocardiographic Outcomes of Sapien 3 Versus Evolut R Bioprosthetic Transcatheter Aortic Valves: A Single-center Retrospective Iranian Cohort Study. Sapien 3与Evolut R生物人工经导管主动脉瓣1年随访超声心动图结果的比较:一项单中心回顾性伊朗队列研究
Q3 Medicine Pub Date : 2023-06-01 DOI: 10.1097/HPC.0000000000000321
Mohammad Sahebjam, Arezou Zoroufian, Alimohammad Hajizeynali, Mojtaba Salarifar, Arash Jalali, Aryan Ayati, Mahkameh Farmanesh

Objective: The current study aimed to compare 1-year echocardiographic outcomes of the new generations of self-expanding (Evolut R) versus balloon-expandable (Sapien 3) bioprosthetic transcatheter aortic valves.

Methods: In this study, gradients and flow velocities obtained from transthoracic Doppler-echocardiography were retrospectively collected from patients who underwent 2 new generations of transcatheter aortic valve implantation interventions with Sapien 3 and Evolut R valves. Patients underwent echocardiography before the procedure and at discharge, 6 months, and 1-year follow-up.

Results: Of the 66 patients, 28 received Sapien 3 and 38 received Evolut R valves. Evolut R valve presented a lower mean gradient at all follow-up time points compared with Sapien 3 valves (14.4 mm Hg, 14.9 mm Hg, 15.5 mm Hg compared with 10.1 mm Hg, 11.6 mm Hg, 11.8 mm Hg, respectively; all P -values <0.001). Small valve sizes of Evolut R, including 23 and 26, had higher echocardiographic mean gradient or peak gradient at the time of discharge compared with larger valves, including sizes 29 and 34 (11.1 mm Hg and 11.2 mm Hg vs. 10.2 mm Hg, 9.1 mm Hg) and 1-year follow-up (11.0 mm Hg, 11.0 mm Hg vs. 9.9 mm Hg, 8.4 mm Hg; all P -values = 0.001). Although Sapien 3 valves demonstrated a higher peak gradient in smaller sizes at discharge (18.44 mm Hg in size 23 vs. 17.9 mm Hg, 16.5 mm Hg in size 26 and 29, respectively; P = 0.001), the peak gradients did not show a statistically significant difference in the 1-year follow-up.

Conclusions: The current study detected significantly lower mean and peak gradients in Evolut R compared with Sapien 3 at all follow-up time points. Furthermore, smaller valve sizes were associated with significantly higher gradients at all follow-ups, regardless of the valve type.

目的:本研究旨在比较新一代自扩式(Evolut R)与球囊可扩式(Sapien 3)经导管生物假体主动脉瓣1年的超声心动图结果。方法:本研究回顾性收集经胸多普勒超声心动图获得的梯度和血流速度,这些患者接受了2代新一代经导管主动脉瓣植入术,采用Sapien 3和Evolut R瓣膜。患者在手术前、出院时、6个月和1年随访时接受超声心动图检查。结果:66例患者中,Sapien 3瓣膜28例,Evolut R瓣膜38例。与Sapien 3瓣膜相比,Evolut R瓣膜在所有随访时间点的平均梯度较低(分别为14.4 mm Hg、14.9 mm Hg、15.5 mm Hg比10.1 mm Hg、11.6 mm Hg、11.8 mm Hg;结论:本研究发现,在所有随访时间点,Evolut R的平均梯度和峰值梯度明显低于Sapien 3。此外,在所有随访中,无论瓣膜类型如何,较小的瓣膜通径与显著较高的梯度相关。
{"title":"Comparison of 1-year Follow-up Echocardiographic Outcomes of Sapien 3 Versus Evolut R Bioprosthetic Transcatheter Aortic Valves: A Single-center Retrospective Iranian Cohort Study.","authors":"Mohammad Sahebjam,&nbsp;Arezou Zoroufian,&nbsp;Alimohammad Hajizeynali,&nbsp;Mojtaba Salarifar,&nbsp;Arash Jalali,&nbsp;Aryan Ayati,&nbsp;Mahkameh Farmanesh","doi":"10.1097/HPC.0000000000000321","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000321","url":null,"abstract":"<p><strong>Objective: </strong>The current study aimed to compare 1-year echocardiographic outcomes of the new generations of self-expanding (Evolut R) versus balloon-expandable (Sapien 3) bioprosthetic transcatheter aortic valves.</p><p><strong>Methods: </strong>In this study, gradients and flow velocities obtained from transthoracic Doppler-echocardiography were retrospectively collected from patients who underwent 2 new generations of transcatheter aortic valve implantation interventions with Sapien 3 and Evolut R valves. Patients underwent echocardiography before the procedure and at discharge, 6 months, and 1-year follow-up.</p><p><strong>Results: </strong>Of the 66 patients, 28 received Sapien 3 and 38 received Evolut R valves. Evolut R valve presented a lower mean gradient at all follow-up time points compared with Sapien 3 valves (14.4 mm Hg, 14.9 mm Hg, 15.5 mm Hg compared with 10.1 mm Hg, 11.6 mm Hg, 11.8 mm Hg, respectively; all P -values <0.001). Small valve sizes of Evolut R, including 23 and 26, had higher echocardiographic mean gradient or peak gradient at the time of discharge compared with larger valves, including sizes 29 and 34 (11.1 mm Hg and 11.2 mm Hg vs. 10.2 mm Hg, 9.1 mm Hg) and 1-year follow-up (11.0 mm Hg, 11.0 mm Hg vs. 9.9 mm Hg, 8.4 mm Hg; all P -values = 0.001). Although Sapien 3 valves demonstrated a higher peak gradient in smaller sizes at discharge (18.44 mm Hg in size 23 vs. 17.9 mm Hg, 16.5 mm Hg in size 26 and 29, respectively; P = 0.001), the peak gradients did not show a statistically significant difference in the 1-year follow-up.</p><p><strong>Conclusions: </strong>The current study detected significantly lower mean and peak gradients in Evolut R compared with Sapien 3 at all follow-up time points. Furthermore, smaller valve sizes were associated with significantly higher gradients at all follow-ups, regardless of the valve type.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10205741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does the Electrocardiogram Machine Interpretation Affect the Ability to Accurately Diagnose ST-Elevation Myocardial Infarction by Emergency Physicians? 心电图机解读是否影响急诊医师准确诊断st段抬高型心肌梗死的能力?
Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1097/HPC.0000000000000310
Yenisleidy Paez Perez, Sarah Rimm, Joseph Bove, Steven Hochman, Tianci Liu, Anthony Catapano, Ninad Shroff, Jessica Lim, Brian Rimm

Introduction: An ST-elevation myocardial infarction (STEMI) can portend significant morbidity and mortality to the patient and therefore must be rapidly diagnosed by an emergency medicine (EM) physician. The primary aim of this study is to determine whether EM physicians are more or less likely to accurately diagnose STEMI on an electrocardiogram (ECG) if they are blinded to the ECG machine interpretation as opposed to if they are provided the ECG machine interpretation.

Methods: We performed a retrospective chart review of adult patients over 18 years of age admitted to our large, urban tertiary care center with a diagnosis of STEMI from January 1, 2016, to December 31, 2017. From these patients' charts, we selected 31 ECGs to create a quiz that was presented twice to a group of emergency physicians. The first quiz contained the 31 ECGs without the computer interpretations revealed. The second quiz, presented to the same physicians 2 weeks later, contained the same set of ECGs with the computer interpretations revealed. Physicians were asked "Based on the ECG above, is there a blocked coronary artery present causing a STEMI?"

Results: Twenty-five EM physicians completed two 31-question ECG quizzes for a total of 1550 ECG interpretations. On the first quiz with computer interpretations blinded, the overall sensitivity in identifying a "true STEMI" was 67.2% with an overall accuracy of 65.6%. On the second quiz in which the ECG machine interpretation was revealed, the overall sensitivity was 66.4% with an accuracy of 65.8 % in correctly identifying a STEMI. The differences in sensitivity and accuracy were not statistically significant.

Conclusion: This study demonstrated no significant difference in physicians blinded versus those unblinded to computer interpretations of possible STEMI.

st段抬高型心肌梗死(STEMI)可能预示着患者显著的发病率和死亡率,因此必须由急诊医学(EM)医师迅速诊断。本研究的主要目的是确定急诊医生是否更有可能准确地诊断STEMI在心电图(ECG)上,如果他们不知道心电图机器解释,而不是如果他们提供心电图机器解释。方法:我们对2016年1月1日至2017年12月31日在我们的大型城市三级医疗中心诊断为STEMI的18岁以上成年患者进行回顾性图表回顾。从这些患者的图表中,我们选择了31个心电图来创建一个测验,向一组急诊医生展示了两次。第一个测试包含31个心电图,但没有计算机解释。第二次测试在两周后提交给同一位医生,包含了同样的一组心电图,并显示了计算机的解释。医生被问到:“根据上述心电图,是否存在导致STEMI的冠状动脉阻塞?”结果:25名急诊医生完成了两个31题的心电图测验,共计1550次心电图解释。在第一次用计算机盲解释的测试中,识别“真正的STEMI”的总体敏感性为67.2%,总体准确性为65.6%。在第二次测试中,心电图机解释显示,在正确识别STEMI方面,总体敏感性为66.4%,准确率为65.8%。敏感性和准确性差异无统计学意义。结论:本研究表明,在计算机对可能的STEMI的解释上,盲法医师与非盲法医师没有显著差异。
{"title":"Does the Electrocardiogram Machine Interpretation Affect the Ability to Accurately Diagnose ST-Elevation Myocardial Infarction by Emergency Physicians?","authors":"Yenisleidy Paez Perez,&nbsp;Sarah Rimm,&nbsp;Joseph Bove,&nbsp;Steven Hochman,&nbsp;Tianci Liu,&nbsp;Anthony Catapano,&nbsp;Ninad Shroff,&nbsp;Jessica Lim,&nbsp;Brian Rimm","doi":"10.1097/HPC.0000000000000310","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000310","url":null,"abstract":"<p><strong>Introduction: </strong>An ST-elevation myocardial infarction (STEMI) can portend significant morbidity and mortality to the patient and therefore must be rapidly diagnosed by an emergency medicine (EM) physician. The primary aim of this study is to determine whether EM physicians are more or less likely to accurately diagnose STEMI on an electrocardiogram (ECG) if they are blinded to the ECG machine interpretation as opposed to if they are provided the ECG machine interpretation.</p><p><strong>Methods: </strong>We performed a retrospective chart review of adult patients over 18 years of age admitted to our large, urban tertiary care center with a diagnosis of STEMI from January 1, 2016, to December 31, 2017. From these patients' charts, we selected 31 ECGs to create a quiz that was presented twice to a group of emergency physicians. The first quiz contained the 31 ECGs without the computer interpretations revealed. The second quiz, presented to the same physicians 2 weeks later, contained the same set of ECGs with the computer interpretations revealed. Physicians were asked \"Based on the ECG above, is there a blocked coronary artery present causing a STEMI?\"</p><p><strong>Results: </strong>Twenty-five EM physicians completed two 31-question ECG quizzes for a total of 1550 ECG interpretations. On the first quiz with computer interpretations blinded, the overall sensitivity in identifying a \"true STEMI\" was 67.2% with an overall accuracy of 65.6%. On the second quiz in which the ECG machine interpretation was revealed, the overall sensitivity was 66.4% with an accuracy of 65.8 % in correctly identifying a STEMI. The differences in sensitivity and accuracy were not statistically significant.</p><p><strong>Conclusion: </strong>This study demonstrated no significant difference in physicians blinded versus those unblinded to computer interpretations of possible STEMI.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10573150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial Arrhythmias. 静脉注射索他洛尔治疗房性心律失常的方案制定和初步经验。
Q3 Medicine Pub Date : 2023-03-01 Epub Date: 2022-12-23 DOI: 10.1097/HPC.0000000000000308
Melissa L Feuerborn, John Dechand, Rohith S Vadlamudi, Michael Torre, Roger A Freedman, Christopher Groh, Leenhapong Navaravong, Ravi Ranjan, Daniel Varela, T Jared Bunch, Benjamin A Steinberg

Background: Oral sotalol is a class III antiarrhythmic commonly used for the maintenance of sinus rhythm in patients with atrial fibrillation (AF). Recently, the Food and Drug Administration (FDA) approved the use of IV sotalol loading, based primarily on modeling data for the infusion. We aimed to describe a protocol and experience with IV sotalol loading for elective treatment of adult patients with AF and atrial flutter (AFL).

Methods: We present our institutional protocol and retrospective review of initial patients treated with IV sotalol for AF/AFL at the University of Utah Hospital between September 2020 and April 2021.

Results: Eleven patients received IV sotalol for initial loading or dose escalation. All patients were male, aged 56-88 years (median 69). Mean QT interval (QTc) intervals increased from baseline (mean 384 ms) immediately after infusion of IV sotalol (mean change 42ms), but no patient required discontinuation of the medication. Six patients were discharged after 1 night; 4 patients were discharged after 2 nights; and 1 patient was discharged after 4 nights. Nine patients underwent electrical cardioversion prior to discharge (2 prior to load; 7 post-load on the day of discharge). There were no adverse events during the infusion or within 6 months of discharge. Persistence of therapy was 73% (8 of 11) at mean 9.9 weeks to follow up, with no discontinuations for adverse effects.

Conclusions: We employed a streamlined protocol that was successfully implemented to facilitate the use of IV sotalol loading for atrial arrhythmias. Our initial experience suggests feasibility, safety, and tolerability while reducing hospitalization duration. Additional data are needed to augment this experience as IV sotalol use is broadened across different patient populations.

背景:口服索他洛尔是一种 III 类抗心律失常药物,常用于维持心房颤动(房颤)患者的窦性心律。最近,美国食品和药物管理局(FDA)批准使用静脉注射索他洛尔,其主要依据是输注的模型数据。我们旨在介绍静脉注射索他洛尔负荷治疗成年房颤和心房扑动(AFL)患者的方案和经验:我们介绍了犹他大学医院在 2020 年 9 月至 2021 年 4 月期间采用静脉注射索他洛尔治疗房颤/心房扑动的初始患者的机构方案和回顾性回顾:11名患者接受了静脉注射索他洛尔的初始负荷或剂量升级治疗。所有患者均为男性,年龄在 56-88 岁之间(中位数为 69 岁)。输注静脉索他洛尔后,平均 QT 间期(QTc)较基线(平均 384 毫秒)立即增加(平均变化 42 毫秒),但没有患者需要停药。6 名患者在 1 晚后出院;4 名患者在 2 晚后出院;1 名患者在 4 晚后出院。9 名患者在出院前进行了心脏电复律(2 名在负荷前;7 名在出院当天负荷后)。输液期间或出院后 6 个月内未发生任何不良事件。在平均9.9周的随访中,治疗持续率为73%(11人中有8人),没有人因不良反应而中断治疗:结论:我们采用了简化的方案,并成功实施了静脉注射索他洛尔治疗房性心律失常。我们的初步经验表明,这种方法具有可行性、安全性和耐受性,同时缩短了住院时间。随着静脉注射索他洛尔在不同患者群体中的使用范围不断扩大,还需要更多数据来丰富这一经验。
{"title":"Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial Arrhythmias.","authors":"Melissa L Feuerborn, John Dechand, Rohith S Vadlamudi, Michael Torre, Roger A Freedman, Christopher Groh, Leenhapong Navaravong, Ravi Ranjan, Daniel Varela, T Jared Bunch, Benjamin A Steinberg","doi":"10.1097/HPC.0000000000000308","DOIUrl":"10.1097/HPC.0000000000000308","url":null,"abstract":"<p><strong>Background: </strong>Oral sotalol is a class III antiarrhythmic commonly used for the maintenance of sinus rhythm in patients with atrial fibrillation (AF). Recently, the Food and Drug Administration (FDA) approved the use of IV sotalol loading, based primarily on modeling data for the infusion. We aimed to describe a protocol and experience with IV sotalol loading for elective treatment of adult patients with AF and atrial flutter (AFL).</p><p><strong>Methods: </strong>We present our institutional protocol and retrospective review of initial patients treated with IV sotalol for AF/AFL at the University of Utah Hospital between September 2020 and April 2021.</p><p><strong>Results: </strong>Eleven patients received IV sotalol for initial loading or dose escalation. All patients were male, aged 56-88 years (median 69). Mean QT interval (QTc) intervals increased from baseline (mean 384 ms) immediately after infusion of IV sotalol (mean change 42ms), but no patient required discontinuation of the medication. Six patients were discharged after 1 night; 4 patients were discharged after 2 nights; and 1 patient was discharged after 4 nights. Nine patients underwent electrical cardioversion prior to discharge (2 prior to load; 7 post-load on the day of discharge). There were no adverse events during the infusion or within 6 months of discharge. Persistence of therapy was 73% (8 of 11) at mean 9.9 weeks to follow up, with no discontinuations for adverse effects.</p><p><strong>Conclusions: </strong>We employed a streamlined protocol that was successfully implemented to facilitate the use of IV sotalol loading for atrial arrhythmias. Our initial experience suggests feasibility, safety, and tolerability while reducing hospitalization duration. Additional data are needed to augment this experience as IV sotalol use is broadened across different patient populations.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10205238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Adapted Self-screening Tool for Peripartum Cardiomyopathy in Haiti. 海地围产期心肌病的适应性自我筛查工具。
Q3 Medicine Pub Date : 2023-03-01 Epub Date: 2023-01-11 DOI: 10.1097/HPC.0000000000000312
Cassandra Rene, Mikerlyne Faustin, Jerry Bonhomme, Marie-Marcelle Deschamps, Michele Jean-Gilles, Rhonda Rosenberg, Michel Ibrahim, Margaret McNairy, Jean W Pape, Jessy G Devieux

Background: Peripartum cardiomyopathy (PPCM) is considered rare in the United States; however, the literature notes that the disease has a higher prevalence in developing countries such as Haiti. Dr. James D. Fett, a US cardiologist, developed and validated a self-assessment measure for PPCM in the United States to aid women to easily differentiate the signs and symptoms of heart failure from those related to a normal pregnancy. Although this instrument was validated, it lacks the adaptation necessary to account for the language, culture, and education of the Haitian population.

Objective: The aim of this study was to translate and culturally adapt the Fett PPCM self-assessment measure for use among a Haitian Creole speaking population.

Methods: A preliminary Haitian Creole direct translation was developed from the original English Fett self-test. A total of four focus groups with medical professionals and 16 cognitive interviews with members of a community advisory board were conducted to refine the preliminary Haitian Creole translation and adaptation.

Results: The adaptation focused on incorporating cues that would be tangible and connected to the reality of the Haitian population while maintaining the intended meaning of the original Fett measure.

Conclusions: The final adaptation provides an instrument suitable for administration by auxiliary health providers and community health workers to help patients distinguish symptoms of heart failure from symptoms related to normal pregnancy and further quantify the severity of signs and symptoms that might be indicative of heart failure.

背景:围产期心肌病(PPCM)在美国被认为是罕见的;然而,文献指出,这种疾病在海地等发展中国家的流行率更高。美国心脏病专家James D.Fett博士开发并验证了美国PPCM的自我评估措施,以帮助女性轻松区分心力衰竭的体征和症状与正常妊娠有关。尽管这一文书得到了验证,但它缺乏必要的调整,无法考虑到海地人口的语言、文化和教育。目的:本研究的目的是在海地克里奥尔语人群中翻译和文化调整Fett PPCM自我评估措施。方法:在原始英语Fett自检的基础上,初步翻译海地克里奥尔语。共进行了四个由医疗专业人员组成的焦点小组,并对社区咨询委员会成员进行了16次认知访谈,以完善海地克里奥尔语的初步翻译和改编。结果:调整的重点是纳入有形的线索,并与海地人口的现实相联系,同时保持原始费特测量的预期含义。结论:最终的适应提供了一种适合辅助卫生提供者和社区卫生工作者使用的工具,以帮助患者区分心力衰竭症状和与正常妊娠相关的症状,并进一步量化可能表明心力衰竭的体征和症状的严重程度。
{"title":"An Adapted Self-screening Tool for Peripartum Cardiomyopathy in Haiti.","authors":"Cassandra Rene, Mikerlyne Faustin, Jerry Bonhomme, Marie-Marcelle Deschamps, Michele Jean-Gilles, Rhonda Rosenberg, Michel Ibrahim, Margaret McNairy, Jean W Pape, Jessy G Devieux","doi":"10.1097/HPC.0000000000000312","DOIUrl":"10.1097/HPC.0000000000000312","url":null,"abstract":"<p><strong>Background: </strong>Peripartum cardiomyopathy (PPCM) is considered rare in the United States; however, the literature notes that the disease has a higher prevalence in developing countries such as Haiti. Dr. James D. Fett, a US cardiologist, developed and validated a self-assessment measure for PPCM in the United States to aid women to easily differentiate the signs and symptoms of heart failure from those related to a normal pregnancy. Although this instrument was validated, it lacks the adaptation necessary to account for the language, culture, and education of the Haitian population.</p><p><strong>Objective: </strong>The aim of this study was to translate and culturally adapt the Fett PPCM self-assessment measure for use among a Haitian Creole speaking population.</p><p><strong>Methods: </strong>A preliminary Haitian Creole direct translation was developed from the original English Fett self-test. A total of four focus groups with medical professionals and 16 cognitive interviews with members of a community advisory board were conducted to refine the preliminary Haitian Creole translation and adaptation.</p><p><strong>Results: </strong>The adaptation focused on incorporating cues that would be tangible and connected to the reality of the Haitian population while maintaining the intended meaning of the original Fett measure.</p><p><strong>Conclusions: </strong>The final adaptation provides an instrument suitable for administration by auxiliary health providers and community health workers to help patients distinguish symptoms of heart failure from symptoms related to normal pregnancy and further quantify the severity of signs and symptoms that might be indicative of heart failure.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10573152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Functional Testing Versus Invasive Cardiac Catheterization for the Evaluation of Intermediate Severity Coronary Stenosis Detected on Cardiac Computed Tomography Angiography. 心脏ct血管造影检测到中度冠状动脉狭窄,功能检查与有创心导管置入评价的结果。
Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1097/HPC.0000000000000309
Aditi A Bhagat, Matthew J Fordham, Minisha Lohani, Getu Teressa

Introduction: The aim of this study was to evaluate the effectiveness of functional testing in comparison to invasive coronary angiography (ICA) among acute chest pain patients whose first diagnostic modality was a coronary computed tomography angiogram (CCTA) and were found to have intermediate coronary stenosis, defined as 50%-70% luminal stenosis.

Methods: We conducted a retrospective review of 4763 acute chest pain patients ≥18 years old who received a CCTA as the initial diagnostic modality. Of these, 118 patients met enrollment criteria and proceeded to either stress test (80/118) or directly to ICA (38/118). The primary outcome was 30-day major adverse cardiac event, consisting of acute myocardial infarction, urgent revascularization, or death.

Results: There was no difference in 30-day major adverse cardiac event among patients who underwent initial stress testing versus directly referred to ICA (0% vs. 2.6%, P = 0.322) following CCTA. The rate of revascularization without acute myocardial infarction was significantly higher among those who underwent ICA versus stress test [36.8% vs. 3.8%, P < 0.0001; adjusted odds ratio: 9.6, 95% confidence interval, 1.8-49.6]. Patients who underwent ICA had a higher rate of catheterization without revascularization within 30 days of the index admission in comparison to those who underwent initial stress testing (55.3% vs. 12.5%, P < 0.0001; adjusted odds ratio: 26.7, 95% confidence interval, 6.6-109.5).

Conclusion: Among patients with intermediate coronary stenosis on CCTA, a functional stress test compared with ICA may prevent unnecessary revascularization and improve cardiac catheterization yield without negatively affecting the 30-day patient safety profile.

简介:本研究的目的是评估功能测试与有创冠状动脉造影(ICA)在急性胸痛患者中的有效性,这些患者的首次诊断方式是冠状动脉计算机断层血管造影(CCTA),发现有中度冠状动脉狭窄,定义为50%-70%管腔狭窄。方法:我们对4763例≥18岁接受CCTA作为初始诊断方式的急性胸痛患者进行了回顾性分析。其中,118名患者符合入组标准,进行了压力测试(80/118)或直接进行了ICA(38/118)。主要终点为30天主要心脏不良事件,包括急性心肌梗死、紧急血运重建术或死亡。结果:在CCTA后进行初始压力测试的患者与直接参考ICA的患者的30天主要不良心脏事件没有差异(0% vs. 2.6%, P = 0.322)。与压力试验相比,ICA组无急性心肌梗死的血运重建率明显更高[36.8% vs. 3.8%, P < 0.0001;校正优势比:9.6,95%可信区间为1.8-49.6]。与接受初始压力测试的患者相比,接受ICA的患者在入院后30天内插管无血运重建的比例更高(55.3% vs. 12.5%, P < 0.0001;校正优势比:26.7,95%可信区间为6.6-109.5)。结论:在CCTA显示的中度冠状动脉狭窄患者中,与ICA相比,功能压力测试可以防止不必要的血运重建,提高心导管插管率,而不会对患者30天的安全性产生负面影响。
{"title":"Outcomes of Functional Testing Versus Invasive Cardiac Catheterization for the Evaluation of Intermediate Severity Coronary Stenosis Detected on Cardiac Computed Tomography Angiography.","authors":"Aditi A Bhagat,&nbsp;Matthew J Fordham,&nbsp;Minisha Lohani,&nbsp;Getu Teressa","doi":"10.1097/HPC.0000000000000309","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000309","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to evaluate the effectiveness of functional testing in comparison to invasive coronary angiography (ICA) among acute chest pain patients whose first diagnostic modality was a coronary computed tomography angiogram (CCTA) and were found to have intermediate coronary stenosis, defined as 50%-70% luminal stenosis.</p><p><strong>Methods: </strong>We conducted a retrospective review of 4763 acute chest pain patients ≥18 years old who received a CCTA as the initial diagnostic modality. Of these, 118 patients met enrollment criteria and proceeded to either stress test (80/118) or directly to ICA (38/118). The primary outcome was 30-day major adverse cardiac event, consisting of acute myocardial infarction, urgent revascularization, or death.</p><p><strong>Results: </strong>There was no difference in 30-day major adverse cardiac event among patients who underwent initial stress testing versus directly referred to ICA (0% vs. 2.6%, P = 0.322) following CCTA. The rate of revascularization without acute myocardial infarction was significantly higher among those who underwent ICA versus stress test [36.8% vs. 3.8%, P < 0.0001; adjusted odds ratio: 9.6, 95% confidence interval, 1.8-49.6]. Patients who underwent ICA had a higher rate of catheterization without revascularization within 30 days of the index admission in comparison to those who underwent initial stress testing (55.3% vs. 12.5%, P < 0.0001; adjusted odds ratio: 26.7, 95% confidence interval, 6.6-109.5).</p><p><strong>Conclusion: </strong>Among patients with intermediate coronary stenosis on CCTA, a functional stress test compared with ICA may prevent unnecessary revascularization and improve cardiac catheterization yield without negatively affecting the 30-day patient safety profile.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10573151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Same-Day Discharge After Left Bundle Area Pacing. 左束区起搏后当日放电。
Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1097/HPC.0000000000000306
Anis John Kadado, Kyle Gobeil, Abdullah Pervaiz, Shayal Pundlik, Ryan Pritham, Yasin Obeidat, Anum Fatima, Khalid Sawalha, Fadi Chalhoub

Background: Left bundle area pacing (LBAP) has emerged as an area that appears to be an attractive alternative to other forms of physiological pacing owing to its ease and favorable pacing parameters. Same-day discharge after conventional pacemakers, implantable cardioverter defibrillators, and more recently leadless pacemakers have become routine, especially after the COVID-19 pandemic. With the advent of LBAP, the safety and feasibility of same-day discharge remain unclear.

Methods: This is a retrospective, observational case series of consecutive, sequential patients undergoing LBAP at Baystate Medical Center, an academic teaching hospital. We included all patients who underwent LBAP and were discharged on the same day of procedure completion. Safety parameters included any procedure-related complications including pneumothorax, cardiac tamponade, septal perforation, and lead dislodgement. Pacemaker parameters included pacing threshold, R-wave amplitude, and lead impedance pre-discharge the following day of implantation and up to 6 months of follow-up.

Results: A total of 11 patients were included in our analysis, the average age was 70.3 ± 6.74 years. The most common indication for pacemaker insertion was AV block (73%). No complications were seen in any of the patients. The average time between the procedure and discharge was 5.6 hours. Pacemaker and lead parameters were stable after 6 months of follow-up.

Conclusions: In this case series, we find that same-day discharge after LBAP for any indication is a safe and feasible option. As this mode of pacing becomes increasingly more common, larger prospective studies evaluating the safety and feasibility of early discharge after LBAP will be needed.

背景:左束区域起搏(LBAP)由于其易于使用和有利的起搏参数,已成为其他形式的生理起搏的一个有吸引力的替代区域。在使用传统起搏器、植入式心律转复除颤器和最近的无铅起搏器后,当天出院已成为常规,尤其是在2019冠状病毒病大流行之后。随着LBAP的出现,当日排放的安全性和可行性仍不清楚。方法:这是一个回顾性的、观察性的病例系列,连续的、顺序的患者在Baystate医学中心,一个学术教学医院接受LBAP。我们纳入了所有接受LBAP并在手术完成当天出院的患者。安全性参数包括任何手术相关并发症,包括气胸、心包填塞、间隔穿孔和导联脱位。起搏器参数包括起搏阈值、r波振幅和导联阻抗,在植入次日和6个月的随访中进行预放电。结果:共纳入11例患者,平均年龄70.3±6.74岁。起搏器植入最常见的适应症是房室阻滞(73%)。所有患者均未出现并发症。从手术到出院的平均时间为5.6小时。随访6个月起搏器及导联参数稳定。结论:在本病例系列中,我们发现LBAP术后当天出院对于任何适应症都是安全可行的选择。随着这种起搏模式变得越来越普遍,需要更大规模的前瞻性研究来评估LBAP术后早期出院的安全性和可行性。
{"title":"Same-Day Discharge After Left Bundle Area Pacing.","authors":"Anis John Kadado,&nbsp;Kyle Gobeil,&nbsp;Abdullah Pervaiz,&nbsp;Shayal Pundlik,&nbsp;Ryan Pritham,&nbsp;Yasin Obeidat,&nbsp;Anum Fatima,&nbsp;Khalid Sawalha,&nbsp;Fadi Chalhoub","doi":"10.1097/HPC.0000000000000306","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000306","url":null,"abstract":"<p><strong>Background: </strong>Left bundle area pacing (LBAP) has emerged as an area that appears to be an attractive alternative to other forms of physiological pacing owing to its ease and favorable pacing parameters. Same-day discharge after conventional pacemakers, implantable cardioverter defibrillators, and more recently leadless pacemakers have become routine, especially after the COVID-19 pandemic. With the advent of LBAP, the safety and feasibility of same-day discharge remain unclear.</p><p><strong>Methods: </strong>This is a retrospective, observational case series of consecutive, sequential patients undergoing LBAP at Baystate Medical Center, an academic teaching hospital. We included all patients who underwent LBAP and were discharged on the same day of procedure completion. Safety parameters included any procedure-related complications including pneumothorax, cardiac tamponade, septal perforation, and lead dislodgement. Pacemaker parameters included pacing threshold, R-wave amplitude, and lead impedance pre-discharge the following day of implantation and up to 6 months of follow-up.</p><p><strong>Results: </strong>A total of 11 patients were included in our analysis, the average age was 70.3 ± 6.74 years. The most common indication for pacemaker insertion was AV block (73%). No complications were seen in any of the patients. The average time between the procedure and discharge was 5.6 hours. Pacemaker and lead parameters were stable after 6 months of follow-up.</p><p><strong>Conclusions: </strong>In this case series, we find that same-day discharge after LBAP for any indication is a safe and feasible option. As this mode of pacing becomes increasingly more common, larger prospective studies evaluating the safety and feasibility of early discharge after LBAP will be needed.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9668105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pilot Study on Standardized In-hospital Education About Heart Failure Conducted During the First Days After Decompensation. 代偿后第一天心衰规范化住院教育的试点研究
Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1097/HPC.0000000000000313
Agnieszka Siennicka, Jan Biegus, Piotr Gajewski, Katarzyna Młynarska, Mateusz Sokolski, Paweł Siwołowski, Robert Zymliński, Kamila Jedynak, Beata Ponikowska, Szymon Urban

Introduction: Education addressed to heart failure (HF) patients constitutes an important element of modern comprehensive treatment programs. The present article demonstrates a novel method of standardized in-hospital education addressed to patients admitted due to decompensation in HF.

Methods: This pilot study was conducted among 20 patients [19 men, age 63 ± 16 years, NYHA (Classification according to New York Heart Association) on admission (II/III/IV): 5/25/70%]. Five-day education was based on individual sessions conducted using colorful boards demonstrating selected, highly practical elements of the knowledge about HF management, prepared by experts in HF management (medical doctors, a psychologist, and a dietician). The level of knowledge about HF was measured before and after education, based on a questionnaire prepared by the authors of the boards.

Results: All patients experienced an improvement of their clinical status (confirmed by reduced New York Heart Association class and body mass, both P < 0.05). Mini Mental State Exam (MMSE) confirmed that no one demonstrated cognitive impairment. The score reflecting the level of knowledge about HF improved significantly after 5 days of in-hospital treatment accompanied by education (P = 0.0001).

Conclusions: We showed that the proposed model of education addressed to patients with decompensated HF, conducted using colorful boards demonstrating selected, highly practical elements of the knowledge about HF management, prepared by experts in HF management lead to significant increase of HF-related knowledge.

对心力衰竭(HF)患者的教育是现代综合治疗方案的重要组成部分。本文介绍了一种针对心力衰竭失代偿患者的标准化住院教育的新方法。方法:本初步研究纳入20例患者[19例男性,年龄63±16岁,入院时NYHA(根据纽约心脏协会分类)(II/III/IV): 5/25/70%]。为期5天的教育以个别课程为基础,使用彩色板展示心衰管理方面精选的、高度实用的知识要素,由心衰管理专家(医生、心理学家和营养师)准备。在教育前后,根据委员会作者准备的调查问卷,对HF的知识水平进行测量。结果:所有患者的临床状况均有改善(纽约心脏协会分级降低,体重下降,均P < 0.05)。迷你精神状态检查(MMSE)证实没有人表现出认知障碍。住院治疗伴教育5天后,反映HF知识水平的得分显著提高(P = 0.0001)。结论:我们提出的针对失代偿性HF患者的教育模式,使用彩色板展示HF管理专家准备的精选的、高度实用的HF管理知识元素,导致HF相关知识的显著增加。
{"title":"A Pilot Study on Standardized In-hospital Education About Heart Failure Conducted During the First Days After Decompensation.","authors":"Agnieszka Siennicka,&nbsp;Jan Biegus,&nbsp;Piotr Gajewski,&nbsp;Katarzyna Młynarska,&nbsp;Mateusz Sokolski,&nbsp;Paweł Siwołowski,&nbsp;Robert Zymliński,&nbsp;Kamila Jedynak,&nbsp;Beata Ponikowska,&nbsp;Szymon Urban","doi":"10.1097/HPC.0000000000000313","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000313","url":null,"abstract":"<p><strong>Introduction: </strong>Education addressed to heart failure (HF) patients constitutes an important element of modern comprehensive treatment programs. The present article demonstrates a novel method of standardized in-hospital education addressed to patients admitted due to decompensation in HF.</p><p><strong>Methods: </strong>This pilot study was conducted among 20 patients [19 men, age 63 ± 16 years, NYHA (Classification according to New York Heart Association) on admission (II/III/IV): 5/25/70%]. Five-day education was based on individual sessions conducted using colorful boards demonstrating selected, highly practical elements of the knowledge about HF management, prepared by experts in HF management (medical doctors, a psychologist, and a dietician). The level of knowledge about HF was measured before and after education, based on a questionnaire prepared by the authors of the boards.</p><p><strong>Results: </strong>All patients experienced an improvement of their clinical status (confirmed by reduced New York Heart Association class and body mass, both P < 0.05). Mini Mental State Exam (MMSE) confirmed that no one demonstrated cognitive impairment. The score reflecting the level of knowledge about HF improved significantly after 5 days of in-hospital treatment accompanied by education (P = 0.0001).</p><p><strong>Conclusions: </strong>We showed that the proposed model of education addressed to patients with decompensated HF, conducted using colorful boards demonstrating selected, highly practical elements of the knowledge about HF management, prepared by experts in HF management lead to significant increase of HF-related knowledge.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10205239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erythrocyte Indices in Patients With Takotsubo Syndrome. Takotsubo综合征患者红细胞指数的变化。
Q3 Medicine Pub Date : 2023-03-01 DOI: 10.1097/HPC.0000000000000311
Annabella Braschi, Arian Frasheri, Renzo M Lombardo, Maurizio G Abrignani, Rosalia Lo Presti, Daniele Vinci, Marcello Traina

Background: Although the prognosis of patients with Takotsubo syndrome (TTS) is relatively favorable, serious complications may occur. This study aimed to investigate the relationship between blood parameters and the occurrence of in-hospital complications.

Methods: Clinical charts of 51 patients with TTS were retrospectively evaluated, and data regarding blood parameters assessed during the first 24 hours of hospitalization were studied.

Results: Levels of hemoglobin less than 13 g/dL in men and 12 g/dL in women (P < 0.01), levels of mean corpuscular hemoglobin concentration (MCHC) less than 33 g/dL (P = 0.01), and levels of red blood cell distribution width-coefficient of variation higher than 14.5% (P = 0.01) were significantly associated to the occurrence of major adverse cardiovascular events (MACE). Markers, such as, platelets to lymphocytes ratio, lymphocytes to monocytes ratio, neutrophils to lymphocytes ratio, and white blood cell count to mean platelet volume, were unable to differentiate patients with and without complications (P > 0.05). MCHC and estimated glomerular filtration rate were independent predictors of MACE.

Conclusions: Blood parameters may have a role in the stratification risk of patients with TTS. Patients showing low levels of MCHC and decreased estimated glomerular filtration rate were more likely to have in-hospital MACE. This should encourage physicians to closely monitor blood parameters in patients with TTS.

背景:Takotsubo综合征(TTS)患者虽然预后较好,但也可能出现严重的并发症。本研究旨在探讨血液指标与院内并发症发生的关系。方法:回顾性分析51例TTS患者的临床资料,分析入院前24小时血液指标。结果:男性血红蛋白< 13 g/dL、女性血红蛋白< 12 g/dL (P < 0.01)、红细胞平均血红蛋白浓度< 33 g/dL (P = 0.01)、红细胞分布宽度变异系数> 14.5% (P = 0.01)与主要心血管不良事件(MACE)的发生有显著相关性。血小板/淋巴细胞比、淋巴细胞/单核细胞比、中性粒细胞/淋巴细胞比、白细胞计数/平均血小板体积等指标无法区分有无并发症(P > 0.05)。MCHC和肾小球滤过率是MACE的独立预测因子。结论:血液参数可能在TTS患者分层风险中起作用。MCHC水平低且肾小球滤过率降低的患者更有可能发生院内MACE。这应该鼓励医生密切监测TTS患者的血液参数。
{"title":"Erythrocyte Indices in Patients With Takotsubo Syndrome.","authors":"Annabella Braschi,&nbsp;Arian Frasheri,&nbsp;Renzo M Lombardo,&nbsp;Maurizio G Abrignani,&nbsp;Rosalia Lo Presti,&nbsp;Daniele Vinci,&nbsp;Marcello Traina","doi":"10.1097/HPC.0000000000000311","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000311","url":null,"abstract":"<p><strong>Background: </strong>Although the prognosis of patients with Takotsubo syndrome (TTS) is relatively favorable, serious complications may occur. This study aimed to investigate the relationship between blood parameters and the occurrence of in-hospital complications.</p><p><strong>Methods: </strong>Clinical charts of 51 patients with TTS were retrospectively evaluated, and data regarding blood parameters assessed during the first 24 hours of hospitalization were studied.</p><p><strong>Results: </strong>Levels of hemoglobin less than 13 g/dL in men and 12 g/dL in women (P < 0.01), levels of mean corpuscular hemoglobin concentration (MCHC) less than 33 g/dL (P = 0.01), and levels of red blood cell distribution width-coefficient of variation higher than 14.5% (P = 0.01) were significantly associated to the occurrence of major adverse cardiovascular events (MACE). Markers, such as, platelets to lymphocytes ratio, lymphocytes to monocytes ratio, neutrophils to lymphocytes ratio, and white blood cell count to mean platelet volume, were unable to differentiate patients with and without complications (P > 0.05). MCHC and estimated glomerular filtration rate were independent predictors of MACE.</p><p><strong>Conclusions: </strong>Blood parameters may have a role in the stratification risk of patients with TTS. Patients showing low levels of MCHC and decreased estimated glomerular filtration rate were more likely to have in-hospital MACE. This should encourage physicians to closely monitor blood parameters in patients with TTS.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10573154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Critical Pathways in Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1